By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market Thursday that its second-quarter revenues declined 2 percent year over year, as blood screening revenues dropped sharply.

The San Diego-based molecular diagnostics firm brought in total revenues of $135.9 million for the three-month period ended June 30, compared with revenues of $138.6 million for the second quarter of 2010. Product sales were virtually flat at $132.9 million versus $132.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.